Eye Catching Stocks: AbbVie Inc. (NYSE:ABBV), DepoMed Inc. (NASDAQ:DEPO), Misonix Inc. (NASDAQ:MSON), Bebe Stores, Inc. (NASDAQ:BEBE)

AbbVie (NASDAQ:ABBV) had its target price boosted by Credit Suisse from $60.00 to $63.00 in a report issued on Wednesday. They currently have an outperform rating on the stock.AbbVie Inc. (NYSE:ABBV) shares moved down -0.21% in last trading session and ended the day at $55.75. ABBV Gross Margin is 76.40% and its return on assets is 14.50%. AbbVie Inc. (NYSE:ABBV) quarterly performance is 3.89%.

DepoMed Inc. (NASDAQ:DEPO) announced that it will be presenting at the Morgan Stanley 2014 Global Healthcare Conference in New York City. On 26 August, DepoMed Inc. (NASDAQ:DEPO) shares increased 0.60% and was closed at $15.10. DEPO EPS growth in last 5 year was 34.10%. DepoMed Inc. (NASDAQ:DEPO) year to date (YTD) performance is 42.72%.

Misonix Inc. (NASDAQ:MSON) ended the last trading day at $6.80. Company weekly volatility is calculated as 1.18%and price to cash ratio as 8.84. Misonix Inc. (NASDAQ:MSON) showed a weekly performance of 3.66%.

bebe stores, inc. (NASDAQ:BEBE) today announced that it will host a conference call on Thursday, September 4, 2014 at 1:30 P.M. (PT) / 4:30 P.M. (ET) to discuss its fourth quarter and fiscal 2014 year end results. Bebe Stores, Inc. (NASDAQ:BEBE) shares increased 5.32% in last trading session and ended the day on $2.97. BEBE Gross Margin is 32.00% and its return on assets is -21.30%. Bebe Stores, Inc. (NASDAQ:BEBE) quarterly performance is -26.30%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone